Cytokinetics
CYTK
CYTK
311 hedge funds and large institutions have $4.55B invested in Cytokinetics in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 142 increasing their positions, 104 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
12% less funds holding
Funds holding: 354 → 311 (-43)
18% less capital invested
Capital invested by funds: $5.53B → $4.55B (-$980M)
59% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 71
Holders
311
Holding in Top 10
12
Calls
$216M
Puts
$45.9M
Top Buyers
| 1 | +$253M | |
| 2 | +$31.4M | |
| 3 | +$30.9M | |
| 4 |
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Warszawa,
Poland
|
+$30.4M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$19M |
Top Sellers
| 1 | -$69.2M | |
| 2 | -$66.3M | |
| 3 | -$52.7M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$50.5M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$34.5M |
